Dec 31, 2015

United Therapeutics Q4 2015 Earnings Report

Total Revenue
$405M
Previous year: $346M
+16.9%
EPS
$3.68
Previous year: $3.21
+14.6%
Gross Profit
$380M
Previous year: $331M
+14.8%
Cash and Equivalents
$832M
Previous year: $398M
+109.2%
Free Cash Flow
$351M
Total Assets
$2.18B
Previous year: $1.88B
+15.9%

United Therapeutics

United Therapeutics